ArticleWorld journal of microbiology & biotechnology2026
Integrated chemo-enzymatic strategy for production of functional xylooligosaccharides from sunflower stalk biomass.
Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sunflower stalk biomass (SSB), a xylan rich agro-residue may serve as an efficient substrate for prebiotics-xylooligosaccharides (XOS) production, offering significant application potential for food/pharmaceutical industries. Current study optimized a chemo-enzymatic bioprocess for XOS production from SSB using Design of Experiments, and the XOS were characterized for various biofunctional attributes. Optimization of delignification (1:1 acetic acid 8.74 M : hydrogen peroxide 21.6 M, at 2.07% w/v biomass loading, 44.16 °C, 3.98 h), followed by xylan extraction with NaOH (10.18% biomass loading, 59 °C, and 6.50% NaOH), enhanced the xylan yield (2.44-fold). Purity and thermal stability of xylan were confirmed by FTIR and TGA, respectively. Xylan was hydrolyzed (2%, w/v xylan, 100 IU endoxylanase, 24 h) using an in-house β-xylosidase-free endoxylanase from Aspergillus flavus MG-7 to produce XOS. A high XOS yield (91.37%, w/w) with varying degree of polymerization i.e. xylotetrose (66.53%, w/w), xylotriose (12.96%, w/w), and xylobiose (11.87%, w/w) was obtained. The XOS exhibited strong growth-promoting activity for the probiotic Lactobacillus plantarum M-13, LPM-13 (18.76 log CFU/ml), a positive prebiotic activity score (1.57 relative to E. coli), and significant antioxidant activity (DPPH free radical scavenging activity 88.47% at 5.0 mg/ml). A varying antibacterial activity of cultural filtrate of LPM-13-grown modified MRS (glucose replaced with XOS, 1% w/v) was observed against E. coli 73.62%, Klebsiella sp. 68.24%, P. aeruginosa 64.29%, E. faecalis 57.42%, B. cereus 53.21%, M. luteus 51.73%, S. pneumoniae 47.53%, and P. alcaligenes 34.27%. Results suggest that XOS from SSB may have promising applications in the food, pharmaceutical, and nutraceutical industries.
Indexed as
Identifiers
41998302What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.